Cutaneous Immune-related Adverse Events are Associated with Longer Overall Survival Among Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors
Published: 17 January 2023| Version 1 | DOI: 10.17632/4pgmpzw7ck.1
Contributor:
Yevgeniy SemenovDescription
Supplemental files
Files
Categories
Education by Subject